title: Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
abstract: The most efficacious Mn(III) porphyrinic (MnPs) scavengers of reactive species have positive charges close to the Mn site, whereby they afford thermodynamic and electrostatic facilitation for the reaction with negatively charged species such as O                            (2)                                      (•-)                          and ONOO(-). Those are Mn(III) meso tetrakis(N-alkylpyridinium-2-yl)porphyrins, more specifically MnTE-2-PyP(5+) (AEOL10113) and MnTnHex-2-PyP(5+) (where alkyls are ethyl and n-hexyl, respectively), and their imidazolium analog, MnTDE-2-ImP(5+) (AEOL10150, Mn(III) meso tetrakis(N,N'-diethylimidazolium-2-yl) porphyrin). The efficacy of MnPs in vivo is determined not only by the compound antioxidant potency, but also by its bioavailability. The former is greatly affected by the lipophilicity, size, structure, and overall shape of the compound. These porphyrins have the ability to both eliminate reactive oxygen species and impact the progression of oxidative stress-dependent signaling events. This will effectively lead to the regulation of redox-dependent transcription factors and the suppression of secondary inflammatory- and oxidative stress-mediated immune responses. We have reported on the inhibition of major transcription factors HIF-1α, AP-1, SP-1, and NF-κB by Mn porphyrins. While the prevailing mechanistic view of the suppression of transcription factors activation is via antioxidative action (presumably in cytosol), the pro-oxidative action of MnPs in suppressing NF-κB activation in nucleus has been substantiated. The magnitude of the effect is dependent upon the electrostatic (porphyrin charges) and thermodynamic factors (porphyrin redox ability). The pro-oxidative action of MnPs has been suggested to contribute at least in part to the in vitro anticancer action of MnTE-2-PyP(5+) in the presence of ascorbate, and in vivo when combined with chemotherapy of lymphoma. Given the remarkable therapeutic potential of metalloporphyrins, future studies are warranted to further our understanding of in vivo action/s of Mn porphyrins, particularly with respect to their subcellular distribution.
authors.affiliation: Department of Radiation Oncology, Duke University Medical Center, 281b/285 MSRB I, Durham, NC 27710, USA. ibatinic@duke.edu
authors.forename: Ines
authors.initials: I
authors.lastname: Batinic-Haberle
authors.forename: Ivan
authors.initials: I
authors.lastname: Spasojevic
authors.forename: Hubert M
authors.initials: HM
authors.lastname: Tse
authors.forename: Artak
authors.initials: A
authors.lastname: Tovmasyan
authors.forename: Zrinka
authors.initials: Z
authors.lastname: Rajic
authors.forename: Daret K
authors.initials: DK
authors.lastname: St Clair
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Vujaskovic
authors.forename: Mark W
authors.initials: MW
authors.lastname: Dewhirst
authors.forename: Jon D
authors.initials: JD
authors.lastname: Piganelli
mesh_terms: D000818:Animals; D006801:Humans; D008345:Manganese / Q000737:chemistry / Q000378:metabolism*; D008665:Metalloporphyrins / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects*; D015533:Transcriptional Activation / Q000187:drug effects*
chemical_list: D008665:Metalloporphyrins; D008345:Manganese
references.citation: J Biol Chem. 2007 Jul 13;282(28):20416-24
references.pmid: 17452333
references.citation: J Inorg Biochem. 2006 Nov;100(11):1897-902
references.pmid: 16965820
references.citation: J Biol Chem. 2003 Feb 28;278(9):6831-7
references.pmid: 12475974
references.citation: Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H2719-25
references.pmid: 17660393
references.citation: Amino Acids. 2012 Jan;42(1):117-28
references.pmid: 20559672
references.citation: J Biol Chem. 1994 Sep 23;269(38):23471-6
references.pmid: 8089112
references.citation: Free Radic Biol Med. 2008 Mar 15;44(6):982-9
references.pmid: 18082148
references.citation: Dalton Trans. 2006 Jan 28;(4):617-24
references.pmid: 16402149
references.citation: Cancer Res. 2000 Jul 15;60(14):3927-39
references.pmid: 10919671
references.citation: Free Radic Biol Med. 2009 Sep 15;47(6):675-83
references.pmid: 19527783
references.citation: J Am Chem Soc. 2008 Apr 9;130(14):4604-6
references.pmid: 18341341
references.citation: J Inorg Biochem. 2007 Nov;101(11-12):1875-82
references.pmid: 17723242
references.citation: Expert Opin Investig Drugs. 2006 Nov;15(11):1383-93
references.pmid: 17040198
references.citation: Inorg Chem. 2001 Feb 12;40(4):726-39
references.pmid: 11225116
references.citation: Cancer Res. 2001 Aug 15;61(16):6082-8
references.pmid: 11507057
references.citation: J Am Chem Soc. 1973 May 2;95(9):2786-90
references.pmid: 4632912
references.citation: FASEB J. 2005 Oct;19(12):1734-6
references.pmid: 16081500
references.citation: Am J Physiol Cell Physiol. 2008 Oct;295(4):C849-68
references.pmid: 18684987
references.citation: Free Radic Biol Med. 2004 Jan 15;36(2):233-47
references.pmid: 14744635
references.citation: Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):1028-31
references.pmid: 18439417
references.citation: Free Radic Biol Med. 2009 Oct 1;47(7):917-23
references.pmid: 19631268
references.citation: Free Radic Biol Med. 2009 Jul 1;47(1):72-8
references.pmid: 19361553
references.citation: Chem Res Toxicol. 1999 May;12(5):442-9
references.pmid: 10328755
references.citation: Nat Rev Drug Discov. 2009 Jul;8(7):579-91
references.pmid: 19478820
references.citation: Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):545-52
references.pmid: 16168847
references.citation: Oncogene. 2007 Jun 7;26(27):3941-51
references.pmid: 17213816
references.citation: Mol Pharmacol. 1998 Apr;53(4):795-800
references.pmid: 9547373
references.citation: J Med Chem. 2009 Dec 10;52(23):7868-72
references.pmid: 19954250
references.citation: Biochim Biophys Acta. 2007 Nov;1770(11):1520-7
references.pmid: 17884296
references.citation: J Biol Inorg Chem. 2008 Feb;13(2):289-302
references.pmid: 18046586
references.citation: Free Radic Biol Med. 2008 Jul 15;45(2):201-10
references.pmid: 18457677
references.citation: Neurosci Lett. 2009 Nov 27;466(1):41-6
references.pmid: 19766169
references.citation: Antioxid Redox Signal. 2009 Sep;11(9):2209-22
references.pmid: 19203223
references.citation: Neuroscience. 2009 Dec 1;164(2):702-10
references.pmid: 19607887
references.citation: Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):755-61
references.pmid: 17272744
references.citation: J Neurosci. 2001 Jul 1;21(13):4582-92
references.pmid: 11425886
references.citation: Free Radic Biol Med. 2002 Sep 15;33(6):857-63
references.pmid: 12208373
references.citation: Diabetes. 2004 Oct;53(10):2559-68
references.pmid: 15448084
references.citation: ACS Chem Biol. 2009 Mar 20;4(3):161-77
references.pmid: 19267456
references.citation: Nitric Oxide. 2000 Oct;4(5):526-33
references.pmid: 11020341
references.citation: Ann Neurol. 2005 Aug;58(2):258-65
references.pmid: 16049935
references.citation: Arch Biochem Biophys. 2005 Jul 15;439(2):234-40
references.pmid: 15978540
references.citation: Free Radic Biol Med. 2009 Aug 1;47(3):250-60
references.pmid: 19389472
references.citation: Cancer Cell. 2007 Sep;12(3):230-8
references.pmid: 17785204
references.citation: Mol Cell Biol. 1993 Feb;13(2):852-60
references.pmid: 8423807
references.citation: Amino Acids. 2012 Jan;42(1):139-58
references.pmid: 20454814
references.citation: Dose Response. 2008;6(3):223-38
references.pmid: 18846257
references.citation: Biochem Pharmacol. 2004 Jan 1;67(1):77-85
references.pmid: 14667930
references.citation: Nucleic Acids Res. 1992 Aug 11;20(15):3821-30
references.pmid: 1508666
references.citation: Oncogene. 2001 Apr 30;20(19):2390-400
references.pmid: 11402335
references.citation: Free Radic Biol Med. 2008 Oct 1;45(7):943-9
references.pmid: 18598757
references.citation: J Pharm Biomed Anal. 2009 Dec 5;50(5):1088-91
references.pmid: 19660888
references.citation: Arch Biochem Biophys. 2008 Sep 1;477(1):105-12
references.pmid: 18477465
references.citation: Free Radic Res. 2007 Nov;41(11):1273-82
references.pmid: 17957541
references.citation: J Biol Chem. 1998 Sep 18;273(38):24521-8
references.pmid: 9733746
references.citation: Cancer Cell. 2004 May;5(5):429-41
references.pmid: 15144951
references.citation: Cancer Res. 2005 Feb 15;65(4):1401-5
references.pmid: 15735027
references.citation: Diabetes. 2002 Feb;51(2):347-55
references.pmid: 11812741
references.citation: Arch Biochem Biophys. 1982 Apr 1;214(2):452-63
references.pmid: 6284026
references.citation: Antioxid Redox Signal. 2009 Sep;11(9):2223-43
references.pmid: 19496701
references.citation: Dalton Trans. 2004 Jun 7;(11):1696-702
references.pmid: 15252564
references.citation: Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):573-80
references.pmid: 17236973
references.citation: Free Radic Biol Med. 2006 Sep 15;41(6):937-41
references.pmid: 16934676
references.citation: Free Radic Biol Med. 2009 Oct 1;47(7):992-1004
references.pmid: 19591920
references.citation: J Biol Chem. 2003 Jul 25;278(30):27432-8
references.pmid: 12700236
references.citation: Free Radic Biol Med. 2010 Apr 15;48(8):1034-43
references.pmid: 20096348
references.citation: Redox Rep. 2009;14(6):236-42
references.pmid: 20003708
references.citation: J Pharm Biomed Anal. 2008 Nov 4;48(3):1046-9
references.pmid: 18804338
references.citation: J Biol Chem. 2002 Nov 15;277(46):44548-56
references.pmid: 12213807
references.citation: Free Radic Biol Med. 2009 Jan 15;46(2):212-9
references.pmid: 18983908
references.citation: Biochem Pharmacol. 2003 Oct 15;66(8):1371-9
references.pmid: 14555211
references.citation: Free Radic Biol Med. 2009 Jan 15;46(2):192-201
references.pmid: 19007878
references.citation: Free Radic Biol Med. 2007 Apr 15;42(8):1193-200
references.pmid: 17382200
references.citation: Nucleic Acids Res. 1996 Jun 15;24(12):2236-42
references.pmid: 8710491
references.citation: Am J Med. 2000 Jun 1;108(8):652-9
references.pmid: 10856414
references.citation: Antioxid Redox Signal. 2010 Sep 15;13(6):877-918
references.pmid: 20095865
references.citation: J Immunol. 2002 Jan 15;168(2):825-33
references.pmid: 11777978
references.citation: Free Radic Biol Med. 2006 Aug 1;41(3):503-12
references.pmid: 16843831
references.citation: Antioxid Redox Signal. 2009 Mar;11(3):571-4
references.pmid: 18715142
references.citation: Cancer Res. 2009 Jul 1;69(13):5450-7
references.pmid: 19549914
references.citation: Free Radic Res. 2007 Jan;41(1):8-14
references.pmid: 17164174
references.citation: Int J Radiat Biol Relat Stud Phys Chem Med. 1982 Oct;42(4):449-56
references.pmid: 6293987
references.citation: Antioxid Redox Signal. 2009 Sep;11(9):2057-64
references.pmid: 19422287
references.citation: Free Radic Biol Med. 2007 May 15;42(10):1571-8
references.pmid: 17448904